BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alphonse MP, Rubens JH, Ortines RV, Orlando NA, Patel AM, Dikeman D, Wang Y, Vuong I, Joyce DP, Zhang J, Mumtaz M, Liu H, Liu Q, Youn C, Patrick GJ, Ravipati A, Miller RJ, Archer NK, Miller LS. Pan-caspase inhibition as a potential host-directed immunotherapy against MRSA and other bacterial skin infections. Sci Transl Med 2021;13:eabe9887. [PMID: 34233954 DOI: 10.1126/scitranslmed.abe9887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Keestra-gounder AM, Nagao PE. Inflammasome activation by Gram-positive bacteria: Mechanisms of activation and regulation. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1075834] [Reference Citation Analysis]
2 Huang H, Ali A, Liu Y, Xie H, Ullah S, Roy S, Song Z, Guo B, Xu J. Advances in image-guided drug delivery for antibacterial therapy. Adv Drug Deliv Rev 2023;192:114634. [PMID: 36503884 DOI: 10.1016/j.addr.2022.114634] [Reference Citation Analysis]
3 Pandian N, Kanneganti TD. PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality. J Immunol 2022;209:1625-33. [PMID: 36253067 DOI: 10.4049/jimmunol.2200508] [Reference Citation Analysis]
4 Chen F, Liu Q. Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseases. Adv Drug Deliv Rev 2022;186:114317. [PMID: 35533788 DOI: 10.1016/j.addr.2022.114317] [Reference Citation Analysis]
5 Liao X, Dai Y, Zhao Y, Nie K. Gasdermin E: A Prospective Target for Therapy of Diseases. Front Pharmacol 2022;13:855828. [DOI: 10.3389/fphar.2022.855828] [Reference Citation Analysis]